TY - JOUR
T1 - Advancing Surgical Arrhythmia Ablation
T2 - Novel Insights on 3D Printing Applications and Two Biocompatible Materials
AU - Monaco, Cinzia
AU - Kronenberger, Rani
AU - Talevi, Giacomo
AU - Pannone, Luigi
AU - Cappello, Ida Anna
AU - Candelari, Mara
AU - Ramak, Robbert
AU - Della Rocca, Domenico Giovanni
AU - Bori, Edoardo
AU - Terryn, Herman
AU - Baert, Kitty
AU - Laha, Priya
AU - Krasniqi, Ahmet
AU - Gharaviri, Ali
AU - Bala, Gezim
AU - Chierchia, Gian Battista
AU - La Meir, Mark
AU - Innocenti, Bernardo
AU - de Asmundis, Carlo
N1 - Publisher Copyright:
© 2024 by the authors.
PY - 2024/4
Y1 - 2024/4
N2 - To date, studies assessing the safety profile of 3D printing materials for application in cardiac ablation are sparse. Our aim is to evaluate the safety and feasibility of two biocompatible 3D printing materials, investigating their potential use for intra-procedural guides to navigate surgical cardiac arrhythmia ablation. Herein, we 3D printed various prototypes in varying thicknesses (0.8 mm-3 mm) using a resin (MED625FLX) and a thermoplastic polyurethane elastomer (TPU95A). Geometrical testing was performed to assess the material properties pre- and post-sterilization. Furthermore, we investigated the thermal propagation behavior beneath the 3D printing materials during cryo-energy and radiofrequency ablation using an in vitro wet-lab setup. Moreover, electron microscopy and Raman spectroscopy were performed on biological tissue that had been exposed to the 3D printing materials to assess microparticle release. Post-sterilization assessments revealed that MED625FLX at thicknesses of 1 mm, 2.5 mm, and 3 mm, along with TPU95A at 1 mm and 2.5 mm, maintained geometrical integrity. Thermal analysis revealed that material type, energy source, and their factorial combination with distance from the energy source significantly influenced the temperatures beneath the 3D-printed material. Electron microscopy revealed traces of nitrogen and sulfur underneath the MED625FLX prints (1 mm, 2.5 mm) after cryo-ablation exposure. The other samples were uncontaminated. While Raman spectroscopy did not detect material release, further research is warranted to better understand these findings for application in clinical settings.
AB - To date, studies assessing the safety profile of 3D printing materials for application in cardiac ablation are sparse. Our aim is to evaluate the safety and feasibility of two biocompatible 3D printing materials, investigating their potential use for intra-procedural guides to navigate surgical cardiac arrhythmia ablation. Herein, we 3D printed various prototypes in varying thicknesses (0.8 mm-3 mm) using a resin (MED625FLX) and a thermoplastic polyurethane elastomer (TPU95A). Geometrical testing was performed to assess the material properties pre- and post-sterilization. Furthermore, we investigated the thermal propagation behavior beneath the 3D printing materials during cryo-energy and radiofrequency ablation using an in vitro wet-lab setup. Moreover, electron microscopy and Raman spectroscopy were performed on biological tissue that had been exposed to the 3D printing materials to assess microparticle release. Post-sterilization assessments revealed that MED625FLX at thicknesses of 1 mm, 2.5 mm, and 3 mm, along with TPU95A at 1 mm and 2.5 mm, maintained geometrical integrity. Thermal analysis revealed that material type, energy source, and their factorial combination with distance from the energy source significantly influenced the temperatures beneath the 3D-printed material. Electron microscopy revealed traces of nitrogen and sulfur underneath the MED625FLX prints (1 mm, 2.5 mm) after cryo-ablation exposure. The other samples were uncontaminated. While Raman spectroscopy did not detect material release, further research is warranted to better understand these findings for application in clinical settings.
KW - ablation
KW - additive manufacturing
KW - cardiac
KW - epicardial
KW - material testing
KW - three-dimensional printing (3D printing)
KW - Heart Rate
UR - http://www.scopus.com/inward/record.url?scp=85191409443&partnerID=8YFLogxK
U2 - 10.3390/biomedicines12040869
DO - 10.3390/biomedicines12040869
M3 - Article
C2 - 38672223
AN - SCOPUS:85191409443
VL - 12
JO - Biomedicines
JF - Biomedicines
SN - 2227-9059
IS - 4
M1 - 869
ER -